1,755 filings
Page 33 of 88
SD
nt05h kifo4946lb
2 Jun 14
Conflict minerals disclosure
12:00am
6-K
o4p09h
2 Jun 14
Appoints Sigurdur Olafsson As President and Ceo of Newly Established Global Generic Medicines Group
12:00am
6-K
u2xfa26ngw16
30 May 14
Teva Receives Favorable Court Decision Regarding Generic Celebrex ® Capsules; Teva should receive sole exclusivity for generic Celebrex ® Capsules
12:00am
6-K
sqiv7uxt 2usqi81sjex
29 May 14
Teva to Present at the Jefferies 2014 Global Healthcare Conference
12:00am
6-K
8760 hxx4cjb
27 May 14
Teva Announces Favorable European Patent Office Ruling In COPAXONE® Patent Proceeding
12:00am
6-K
qg3j0qh87low
23 May 14
Teva Received FDA Approval for QVAR® (beclomethasone dipropionate HFA) with Dose Counter
12:00am
6-K
0vinliga4cvp 1u57yz
15 May 14
Teva to Present at the UBS Global Healthcare Conference
12:00am
6-K
xcqcd
13 May 14
Teva Announces FDA Acceptance of sNDA Filing for Pediatric Indication for QNASL® (Beclomethasone Dipropionate) Nasal Aerosol
12:00am
6-K
h9ie364yfa
9 May 14
Teva to Present at the Bank of America Merrill Lynch 2014 Health Care Conference
12:00am
6-K
nhje59cl7a7ph8
8 May 14
Teva Announces COPAXONE® Recognized as “Brand of the Year” byPharmaceutical ExecutiveMagazine
12:00am
6-K
1spnq8bhjvzz9 y4ecyt
5 May 14
Fda Approves Teva’s Synribo® (Omacetaxine Mepesuccinate) for Injection for Home Administration
12:00am
6-K
3vrxu3b9gw
2 May 14
Current report (foreign)
12:00am
6-K
1pj pjwjrzb
1 May 14
Teva Reports First Quarter 2014 Results
12:00am
6-K/A
jxzn714mp 0e
1 May 14
Teva Reports First Quarter 2014 Results
12:00am
6-K
xqqhio7lsd9r8ugl
30 Apr 14
Live Filing
12:00am
6-K
3q2c9liu 68hvqis
30 Apr 14
Live Filing
12:00am
6-K
1eurytb7yt1n9yj
30 Apr 14
Teva Shares New Data on MS Therapies at 66th American Academy of Neurology (AAN) Annual Meeting
12:00am
6-K
jmc2h isyhbyc728d
29 Apr 14
Teva Receives European Marketing Authorization for DuoResp Spiromax® for the Treatment of Asthma and COPD
12:00am
6-K
74e 3pqppj7m
28 Apr 14
Live Filing
12:00am
6-K
4j0 w4kxgu
28 Apr 14
Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment In Japan
12:00am